Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

World Federation of Societies of Biological Psychiatry guidelines for the pharmacological treatment of dementias in primary care

Research output: Contribution to journalJournal articleResearchpeer-review

  1. A comparison of the major depression inventory (MDI) and the beck depression inventory (BDI) in severely depressed patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Feasibility of a culturally tailored dementia information program for minority ethnic communities in Denmark

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Hospital readmissions following infections in dementia: a nationwide and registry-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Barriers in access to dementia care in minority ethnic groups in Denmark: a qualitative study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Dementia increases mortality beyond effects of comorbid conditions: A national registry-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Ralf Ihl
  • Robertas Bunevicius
  • Lutz Frölich
  • Bengt Winblad
  • Lon S Schneider
  • Bruno Dubois
  • Alistair Burns
  • Florence Thibaut
  • Siegfried Kasper
  • Hans-Jürgen Möller
  • WFSBP Task Force on Mental Disorders in Primary Care(Gunhild Waldemar, member)
View graph of relations

OBJECTIVE: To define a practice guideline for biological treatment of dementias for general practitioners in primary care.

METHODS: This paper is a short and practical summary of the World Federation of Biological Psychiatry (WFSBP) guidelines for the Biological treatment of Alzheimer's disease and other dementias for treatment in primary care ( Ihl et al. 2011 ). The recommendations were developed by a task force of international experts in the field and are based on randomized controlled studies.

RESULTS: Anti-dementia medications neither cure, nor arrest, or alter the course of the disease. The type of dementia, the individual symptom constellation and the tolerability and evidence for efficacy should determine what medications should be used. In treating neuropsychiatric symptoms, psychosocial intervention should be the treatment of first choice. For neuropsychiatric symptoms, medications should only be considered when psychosocial interventions are not adequate and after cautious risk-benefit analysis.

CONCLUSIONS: Depending on the diagnostic entity and clinical presentation different anti-dementia drugs can be recommended. These guidelines provide a practical approach for general practitioners managing dementias.

Original languageEnglish
JournalInternational Journal of Psychiatry in Clinical Practice
Volume19
Issue number1
Pages (from-to)2-7
Number of pages6
ISSN1365-1501
DOIs
Publication statusPublished - Mar 2015

    Research areas

  • Dementia, Humans, Nootropic Agents, Practice Guidelines as Topic, Primary Health Care, Societies, Medical

ID: 46260690